After NF1 loss, nearly all ANNUBPs are characterized by the deletion or silencing of the INK4a/ARF (originally called CDKN2A) tumor suppressor locus [15,16,17,18], which is inactivated in the majority of human cancers [15,19,20]. The gene discussed is CDKN2A; the disease is cancer.